Losartan Potassium
Product Images NDC 50090-2882

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-2882). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500902622)

Losartan Potassium 25 mg tablets label from A-S Medication Solutions. The label shows product name, strength, quantity of 30 tablets, storage instructions between 68 to 77 degrees Fahrenheit, and packaging location in Libertyville, IL. It also includes an NDC code, lot number, and a barcode.*

FDA Label Image

Label Image (Lbl500902656)

Packaging label for Losartan Potassium 100 mg tablets from A-S Medication Solutions, Libertyville, IL. The label indicates 90 tablets per container with storage instructions to keep at 68 to 77 degrees Fahrenheit, protected from light. Dosage and package insert information is referenced via a QR code.*

FDA Label Image

Label Image (Lbl500902882)

Losartan Potassium 50 mg tablets label by A-S Medication Solutions. The label states each film-coated tablet contains 50 mg Losartan Potassium. Storage instructions indicate to store between 68 to 77 degrees Fahrenheit and protect from light. The package contains 30 tablets. NDC 50090-2882-0 is visible along with product and lot numbers.*

FDA Label Image

Figure1 (Losartan Fig1)

A line graph comparing the percentage of patients with the primary endpoint over months of study for Losartan Potassium and Atenolol. The graph shows a steadily increasing percentage for both drugs, with Atenolol having a slightly higher percentage throughout the study period. The adjusted risk reduction is noted as 13%, with a p-value of 0.021.*

FDA Label Image

Figure2 (Losartan Fig2)

A line chart comparing the percentage of patients with fatal or non-fatal stroke over 66 months of study between Atenolol and Losartan Potassium. The graph shows a lower stroke incidence with Losartan Potassium, indicating a 25% adjusted risk reduction (p=0.001).*

FDA Label Image

Figure 3 (Losartan Fig3)

A forest plot figure titled 'Primary Endpoint Events within Demographic Subgroups' comparing Losartan Potassium and Atenolol event rates and hazard ratios. It shows two outcomes: Primary Composite and Stroke (Fatal/Non-fatal), across subgroups by age, gender, race, ISH, diabetes, and history of cardiovascular disease. Hazard ratios with 95% confidence intervals are visually represented, indicating whether results favor Losartan Potassium or Atenolol.*

FDA Label Image

Figure-4 (Losartan Fig4)

A line graph comparing the percentage of patients with events over 48 months between Losartan Potassium and placebo groups. The graph shows a lower percentage of events in the Losartan Potassium group, with a reported risk reduction of 16.1% and a p-value of 0.022.*

FDA Label Image

Chemical Structure (Losartan Str)

Chemical structure of Losartan Potassium showing the molecular arrangement of atoms including a chlorinated ring, an imidazole ring, and a potassium ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.